Nortriptyline for Concussion
(PeCon Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether nortriptyline can reduce headaches following a concussion. Participants will be divided into two groups: one will receive nortriptyline, and the other a placebo (a pill with no active medication). Researchers aim to determine if nortriptyline improves symptoms more quickly than the placebo over four weeks. Suitable candidates have experienced a concussion with persistent headaches for at least four weeks and are not currently taking other medications for their concussion, except for common pain relievers like ibuprofen or acetaminophen. As a Phase 4 trial, this research seeks to understand how an already FDA-approved and effective treatment can benefit more patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot be on any medication for concussion other than NSAIDs or acetaminophen.
What is the safety track record for nortriptyline?
Research has shown that nortriptyline is usually well-tolerated by those needing help with headaches after a concussion. Studies have found that nortriptyline can improve symptoms and speed up the return to normal activities, such as attending school and playing sports. Although this medication is being tested for post-concussion headaches, its use in other conditions suggests it is safe. Always consult a healthcare professional about possible side effects before joining a trial.12345
Why are researchers enthusiastic about this study treatment?
Unlike the standard treatments for concussions, which primarily focus on rest and symptom management with medications like acetaminophen or ibuprofen, nortriptyline offers a potentially novel approach. Nortriptyline is a tricyclic antidepressant, and researchers are interested in its ability to alleviate concussion symptoms by modulating neurotransmitters in the brain, which may help reduce headaches and improve mood disturbances often associated with concussions. This mechanism is different from typical pain relievers and could provide a more comprehensive treatment option for concussion symptoms, potentially leading to faster recovery and improved quality of life for patients.
What evidence suggests that nortriptyline might be an effective treatment for concussion?
Research has shown that nortriptyline can protect brain cells and reduce damage in conditions like certain types of strokes. This finding is promising because it suggests nortriptyline might also alleviate symptoms of brain injury, such as headaches after a concussion. Previous studies found that nortriptyline reduced the number of headaches by at least half for many people. Additionally, nortriptyline has fewer side effects than similar medications. In this trial, participants will receive either nortriptyline or a placebo to evaluate its effectiveness in reducing symptoms in people with headaches after a concussion.12367
Who Is on the Research Team?
Patrick Moreno, MD
Principal Investigator
Lancaster General Health Sports Medicine
Laura DiPaolo, MD
Principal Investigator
Lancaster General Health Sports Medicine
Are You a Good Fit for This Trial?
This trial is for young people aged 13-21 who've had a concussion with headaches lasting over 4 weeks. They must be in good health, able to take pills, and not on other concussion meds except common painkillers. Those with severe brain injuries, uncontrolled mental illness, pregnancy, or known allergies to the drug can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either nortriptyline or placebo daily for 4 weeks, along with standard headache treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Nortriptyline
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lancaster General Hospital
Lead Sponsor